Recent Posts by admin
Researchers from other institutions can request to have their studies performed using these biomarkers. sphingotec GmbH , a biotechnology company that develops biomarkers for the detection and management of diseases, has recently signed an agreement with Mayo Clinic to collaborate on the evaluation and use of several biomarkers that may improve the diagnosis of certain…Read more
-scientific paper shows proenkephalin as the new biomarker for the assessment of kidney function as a more accurate marker to timely detect impaired kidney function when compared with conventional methods- HENNIGSDORF, Germany — sphingotec GmbH announces in the early release of September 2017 issue of the Journal of Applied Laboratory Medicine the first review about proenkephalin…Read more
German diagnostic company sphingotec GmbH (Hennigsdorf) and Chinese Company Shuwen Biotech Co. Ltd (Deqing) have signed an agreement to market Sphingotec’s biomarkers portfolio in China. Under the agreement, Shuwen will directly develop and market Sphingotec reliable immunoassays. For acute care, these are the Sphingotest® penKid and Sphingotest® bio-ADM tests, set to improve therapy monitoring and…Read more
Hennigsdorf-Berlin/Cologne – German diagnostics company sphingotec GmbH (Hennigsdorf) and bestbion dx GmbH (Cologne) have signed an agreement to market sphingotec’s innovative sepsis and congestive heart failure test (sphingotest® bio-ADM) and acute kidney function monitoring assay (sphingotest® penKid). Under the agreement, bestbion dx will market both biomarker assays, set to improve therapy monitoring and outcomes in…Read more
Recent Comments by admin
No comments by admin yet.